Is a complete TSX/AVCN research report available?

No complete published report is available for tsx/AVCN (TSX/AVCN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/AVCN (TSX/AVCN)

Toronto Stock Exchange: TSX/AVCN · CAD

CA$0.12

+0.01 (+4.5%)· Recorded snapshot

Market cap	15.1M
Revenue (ttm)	25.3M
Net income (ttm)	-3.7M
EPS (ttm)	-CA$0.03
Shares out	137.7M
Volume	1,474,300
Beta	0.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.3M
Net income (ttm): -3.7M
EPS (ttm): -CA$0.03
Market cap: 15.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TSX/AVCN indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

CAD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	112
Employees Change	25%
Employees Change Percent	28.74
Enterprise value	CAD 24.5M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.87
Isin	CA05368K1003
Last refreshed	2026-09-11
Market cap	CAD 15.1M
Price	CAD 0.12
Price currency	CAD
Rev Per Employee	226,020.92x
Sector	Healthcare
Sic	2834
Symbol	tsx/AVCN
Website	https://www.avicanna.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.65%
EV/Sales	0.97x
FCF yield	-21.07%
P/B ratio	1.08x
P/S ratio	0.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-14.02%
EBITDA Margin	-12.28%
Gross margin	54.59%
Gross Profit	CAD 13.8M
Gross Profit Growth	5.9%
Gross Profit Growth Q	2.05%
Gross Profit Growth3 Y	173.17%
Net Income	CAD -3.7M
Net Income Growth Years	5%
Pretax Margin	-14.75%
Profit Margin	-14.75%
Profit Per Employee	CAD -33,340
ROA	-9.95
Roa5y	-22.37
ROCE	-24.48
ROE	-30.04
Roe5y	-135.3
ROIC	-17.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.28%
Cagr3y	-36.01%
Cagr5y	-36.68%
EPS Growth Years	5
Revenue Growth	-0.23x
Revenue Growth Q	-8.45x
Revenue Growth Qo Q	-15.61x
Revenue Growth Years	8x
Revenue Growth3 Y	58.21x
Revenue Growth5 Y	72.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.14
Assets	CAD 24.1M
Cash	CAD 200,418
Current Assets	CAD 9.4M
Current Liabilities	CAD 9.6M
Debt	CAD 169,564
Debt Equity	CAD 0.01
Debt FCF	CAD -0.05
Equity	CAD 14M
Interest Coverage	-59.15
Liabilities	CAD 10.1M
Long Term Assets	CAD 14.8M
Long Term Liabilities	CAD 488,519
Net Cash	CAD 30,854
Net Cash By Market Cap	CAD 0.2
Net Cash Growth	-81.91%
Net Debt Equity	CAD -0
Tangible Book Value	CAD 3.8M
Tangible Book Value Per Share	CAD 0.03
WACC	6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.97
Inventory Turnover	2.67
Net Working Capital	CAD -306,363
Quick ratio	0.45
Working Capital	CAD -275,509
Working Capital Turnover	CAD -38.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.26%
200-day SMA	0.17
3Y total return	-73.81%
50-day SMA	0.13
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.81%
All Time High	7.4
All Time High Change	-98.51%
All Time High Date	2019-07-18
All Time Low	0.1
All Time Low Change	15.79%
All Time Low Date	2026-07-08
ATR	0.01
Beta	0.35
Beta1y	0.58
Beta2y	1.26
Ch YTD	-51.11
High	0.12
High52	0.3
High52 Date	2025-10-15
High52ch	-61.34%
Low	0.1
Low52	0.1
Low52 Date	2026-07-08
Low52ch	21.05%
Ma50ch	-12.56%
Price vs 200-day SMA	-33.41%
RSI	40.06
RSI Monthly	32.88
RSI Weekly	31.49
Sharpe ratio	-1.07x
Sharpe Ratio3y	0.06x
Sharpe Ratio5y	-0.05x
Sortino ratio	-1.37
Sortino Ratio3y	0.15
Sortino Ratio5y	-0.01
Total Return	-9.7%
Tr YTD	-51.11
Tr1m	-18.52%
Tr1w	-8.33%
Tr3m	-4.35%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120,798,818%
Net Borrowing	-199,016
Shares Insiders	10.66%
Shares Institutions	9.38%
Shares Out	137,717,185
Shares Qo Q	6.01%
Shares Yo Y	9.7%
Short Float	0.13%
Short Shares	0.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -4.5M
Adjusted OCF	-4,306,402
Average Volume	86,060.5x
Bv Per Share	0.03
CAPEX	CAD -206,876
Ch1m	-18.52
Ch1w	-8.33
Ch1y	-59.26
Ch3m	-4.35
Ch3y	-73.81
Ch5y	-89.81
Ch6m	-40.54
Change	4.55%
Change From Open	4.55
Close	0.11
Days Gap	0
Depreciation Amortization	440,858
Dollar Volume	169,544.5
Earnings Date	2026-11-13
EBIT	CAD -3.5M
EBITDA	CAD -3.1M
EPS	CAD -0.03
F Score	3
FCF	CAD -3.2M
FCF EV Yield	-13.01x
FCF Per Share	CAD -0.02
Financing CF	3,026,846
Fiscal Year End	December
Founded	2,016
Goodwill	334,000
Investing CF	-207,877
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2026-06-30
Ma150	0.14
Ma150ch	-23.45%
Ma20	0.13
Ma20ch	-13.59%
Net CF	-7,220
Next Earnings Date	2026-11-13
Open	0.11
Position In Range	100
Ppne	13,936,107
Price Date	2026-09-10
Ptbv Ratio	4.03
Relative Volume	17.13x
Revenue	25,314,343x
SBC By Revenue	5.22x
Share Based Comp	1,321,271
Tr6m	-40.54%
Volume	1,474,300
Z Score	-4.15

TSX/AVCN (TSX/AVCN)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/AVCN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/AVCN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TSX/AVCN

Frequently asked questions